Question 1

What is the catalog number for RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human) is 39633121.

Question 2

What sizes are available for RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 5

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

RMI1 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Anti-SEPT6/SEPTIN6 Antibody Picoband®, Carrier-free

Human ErbB-2 ELISA Kit PicoKine®

CD19 (B-Lymphocyte Marker) (CD19/3117), CF405S conjugate, 0.1mg/mL

Ubiquitin (Autophagy Marker) (UBB/2122), CF740 conjugate, 0.1mg/mL

P34 / cdk1 (POH-1), CF405S conjugate, 0.1mg/mL

Anti-CD79a Antibody Picoband® (iFluor647 Conjugate)